Podcasts about tirzepatide

In this episode of the Irresistible You podcast, we're talking about the importance of finding your soul snack—something that feeds your soul so you're not constantly turning to food for comfort. Since Chuy passed away, my nights have felt painfully quiet. He was my constant companion during the late-night hours when the house finally settled. That kind of loss leaves a void, but here's the thing… I didn't slip back into emotional eating, and that's because I already had the Irresistible You framework to guide me.One of the most powerful tools in that framework? Feed Your Soul.Lately, diamond painting has been helping me fill that space with peace instead of food. Let's talk about why you need a soul snack and how to find one that works for you.If you've ever reached for food when what you really needed was something deeper, this episode is for you.

You've heard all the buzz around tirzepatide—and maybe you're even taking it—but you're not seeing the results you hoped for. You're not alone. In this eye-opening episode, Dr. Jen White breaks down the real reasons why this powerful peptide may not be delivering its full potential yet—and exactly what you can do about it. From insulin resistance and inflammation to increased energy and vitality, tirzepatide, has the potential to transform your health. But it's not a quick fix, and Dr. Jen shares the foundational pieces that must be in place to unlock its magic.  Whether you're just getting started or have been cycling this peptide for a while, this episode will help you reframe, refocus, and take empowered action in your health journey. Themes:  Why tirzepatide is not new—and why that's actually a good thing The true benefits: improved blood sugar, lower inflammation, metabolic reset How to optimize your dosing with intuition and personalization Why your body needs a solid health foundation first (think: sleep, nutrition, movement) The role of patience—results can take weeks or even months How cycling on and off tirzepatide can improve long-term outcomes The power of advocating for yourself in treatment and dosing Why tirzepatide could be a miracle solution—but only with a holistic approach   Connect with Jen: 

Ever wondered how people make dramatic body transformations that actually last? In this raw and honest episode, Dave Kennedy opens up about his five-year journey from 320 pounds to the best shape of his life at age 42."How do you do it?" Dave reveals it's not about quick fixes or miracle diets, but rather a "system of disciplines, a system of regiments, a system of consistency" built gradually over time. Both hosts break down the common misconceptions around fitness transformations, explaining why dramatic overnight changes rarely stick. Instead, they advocate for building small, sustainable habits that eventually become lifestyle changes.The conversation tackles the hierarchy of importance in fitness: why food management trumps exercise when starting out, how to separate the roles of calorie management, cardio, and resistance training, and the vital importance of patience. Dave shares candid insights about formerly weighing 320 pounds and how tracking calories fundamentally changed his relationship with food, while Ben offers practical frameworks for approaching fitness as a long-term journey rather than a quick sprint.They don't shy away from discussing controversial topics like GLP-1 agonists (Semaglutide, Tirzepatide), acknowledging their benefits while emphasizing they're not substitutes for building proper habits. Perhaps most powerfully, they explore how community support creates accountability and knowledge-sharing that dramatically increases success rates.Whether you're just starting your fitness journey or trying to break through a plateau, this episode delivers actionable wisdom from two people who've both lived the transformation process. Subscribe, share with someone who needs to hear this message, and join us in building sustainable systems that change lives.Support the showCheck out Overclock and Protein Protocol hereWant to know more about coaching? Book a call with Ben here Where to find usWe Hack Health: TwitterWe Hack Health: InstagramWe Hack Health: Discord

This week's topics include USPSTF on screening for syphilis in pregnancy, when to take blood pressure medicines, comparing weight loss drugs, and a narrative intervention for PTSD after an ICU stay.Program notes:0:40 NEJM publication of comparison of obesity medications1:40 Tirzepatide versus semaglutide for 72 weeks2:41 Also had reduction in blood pressure3:26 Rise in congenital syphilis and screening4:26 Disparities among various groups5:26 Highest incidence in the last 30 years6:26 In 2023 210,000 cases of syphilis7:00 When to take blood pressure meds8:00 Monitored blood pressure in a subset8:40 Intervention for PTSD after ICU stay9:40 Self reported PTSD symptoms​​10:40 Must learn to deliver intervention11:40 Physician needed to spend 45 minutes per visit12:42 End

Get My Book On Amazon: https://a.co/d/avbaV48Download The Peptide Cheat Sheet: https://peptidecheatsheet.carrd.co/Download The Bioregulator Cheat Sheet: https://bioregulatorcheatsheet.carrd.co/

Taking Ozempic or Wegovy but still feeling bloated, exhausted, or stuck with your weight? In this episode of Beyond Diagnosis, host Rita De Michele interviews Nutritional Therapist Joanne Posey to break down the missing piece of the GLP-1 puzzle: nutrition and lifestyle. Learn what to eat, how to manage side effects, and what women in menopause really need to know to make GLP-1 medications work with their bodies, not against them. If you're ready for lasting results and better health, this is your next step. Connect with Joanne  https://www.instagram.com/lifelessonsnutritionAsk Rita a QuestionWelcome to Beyond Diagnosis, a podcast that will raise your awareness, decisions, and voice for Alternative practices, so you can take back control of your health. By subscribing, you will gain access to content for people who have long-term health issues, and connect with functional, wellbeing and mindset professionals.

I've been waiting a long time to release this one. Dr. Tyna Moore is someone I've wanted to bring on the show because her take on GLP-1s like Ozempic, Wegovy, and Tirzepatide is so refreshingly honest and grounded in both science and clinical experience. There's so much confusion, fear, and flat-out propaganda around these peptides, and today, we clear the air. We talk about how GLP-1 agonists work not just as weight-loss drugs but as powerful regenerative and neuroprotective tools. Yes, they help you stop obsessively thinking about food. Yes, they can dramatically help with insulin resistance. But the real story? These peptides might help heal your metabolism for good. Tyna doesn't hold back. We unpack the massive industry bias against these drugs, the obesity stigma nobody wants to talk about, and the misinformation that's keeping people sick, scared, and stuck. If you've ever wondered whether peptides are a shortcut or a real solution, this episode lays it all out. And if you're using these tools without lifting weights, optimizing sleep, eating real food, and managing your circadian rhythm? You're setting yourself up for muscle loss and disappointment. GLP-1s are not a miracle. They're a tool. But if you use them the right way, they just might change your life.   "I think there's magic in time under treatment with this peptide. I think the longer somebody's on it, the more long-term healing and regenerative benefits we ultimately get." ~ Dr. Tyna Moore   In This Episode: - GLP-1s explained: Ozempic, Wegovy, Mounjaro  - Benefits beyond weight loss: cardiovascular, neurological, regenerative - Why the pushback against Ozempic? - Muscle loss myths - Addressing other common myths and side effects - The emotional side of weight loss - The metabolic dysfunction epidemic and why it starts early - Proper GLP-1 dosing strategies: "low and slow" approach - Dr. Tyna's free resources and education courses For more, visit https://myersdetox.com    Heavy Metals Quiz: Find out your toxicity score and receive a free video series on detoxification at https://heavymetalsquiz.com    Resources Mentioned: Puori PW1 Protein Powder: Get 20% off with code WENDY at https://puori.com/wendy  Tru Energy Skincare: Get a special deal at https://trytruenergy.com/wendy  Organifi Collagen: Save 20% with code MYERSDETOX at https://organifi.com/myersdetox  Fresh Pressed Olive Oil: Get a $39 bottle for just $1 to cover shipping at https://getfreshwendy.com    About Dr. Tyna Moore: Dr. Tyna Moore is an expert in holistic regenerative medicine and resilient metabolic health with nearly 30 years in the medical field. As both a licensed naturopathic physician and chiropractor, she brings a comprehensive perspective to metabolic health, drawing from traditional and alternative medicine. Dr. Moore has made waves with her open-minded exploration of peptides like semaglutide (Ozempic) as tools for healing and longevity. She champions medical autonomy and individual accountability while hosting The Dr. Tyna Show podcast and speaking internationally. Learn more at: https://drtyna.com    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Today we're diving into how to source peptides safely.  We'll talk about why where you live matters, how to find a reputable provider, and the red flags to watch out for. So if you've been curious about peptides but unsure where to start, this podcast is for you.  Why Peptides? And Why You Need to Be Cautious So first, what are peptides? In short, they're short chains of amino acids—basically, the building blocks of proteins—that signal your body to perform specific actions. Some stimulate growth hormone, others help with weight loss, repair tissue, or improve cognition. Sounds amazing, right? And they can be. But, only when used safely and under the guidance of a qualified provider. Peptides aren't regulated the way pharmaceuticals are, so it's incredibly easy to run into unlicensed sources, impure peptides, or outright scams. Why Where You Live Matters Let's talk geography for a minute. Depending on where you live—whether that's in the U.S., Canada, Mexico, or Europe and other parts of the world—the legal status and availability of peptides vary widely. In the U.S., many peptides are still considered “research chemicals,” meaning they can be sold online but not legally for human use unless prescribed by a licensed provider working with a compounding pharmacy regulated by the FDA. In Canada, peptides are more restricted, and access may require going through clinical trials or specific wellness clinics. Interestingly, in parts of Europe, peptides like BPC-157 have been in clinical use since the 1990s, as it was originally developed and researched in Croatia. So what's the takeaway? The laws in your region affect what's legal, what's safe, and what kind of provider you should be working with. That's why it's important to find someone who not only understands peptide therapy but also works within your country's regulatory framework. How to Find a Reputable Peptide Therapy Provider So now you're wondering: Okay, then who DO I trust? Great question. Let's go over some things you should look for when wanting to start a particular peptide therapy. Credentials Your provider should be a licensed clinician—an MD, DO, PharmD, PA, or NP—with specific training in peptide therapy, functional, or regenerative medicine. Bonus points if they're certified by organizations like SSRP (Seeds Scientific Research & Performance), the A4M (American Academy of Anti-Aging Medicine), or IFM  (Institute for Functional Medicine). Provider Works with Licensed Compounding Pharmacies or Peptide Manufacturers Avoid providers who suggest buying your peptides online or mixing them at home. Thorough Evaluation Process Prior to Treatment The first and most critical step in a full medical workup is gathering a comprehensive medical history. This includes a detailed review of your personal health background—such as any chronic conditions, previous illnesses, surgeries, or hospitalizations—as well as your current medications and supplements. Your provider will also explore your family medical history to identify any contraindications to peptide therapy. Laboratory testing may be obtained if clinically indicated depending on the particular peptide therapy and based on your symptoms, medical history, and treatment goals. Another key component of a full medical workup is the functional assessment, which goes beyond lab numbers to evaluate how your body is actually performing day to day.  This includes an in-depth discussion of your sleep quality, energy levels, cognitive function, mood, libido, and overall sense of well-being. Your provider may also ask about your ability to recover from exercise, your stress resilience, and whether you're experiencing symptoms like brain fog, fatigue, or low motivation. For those seeking peptide therapy for performance or longevity, this assessment helps establish baseline functioning and goals, so treatment can be tailored not just to correct deficiencies, but to optimize quality of life and daily performance. Follow-up Care and Dosing Guidance Peptides aren't one-size-fits-all. You need personalized dosing, cycle recommendations, peptide stacking, and monitoring. If you're not getting that, you're not being cared for safely. Red Flags  “For research only” Let's get real and talk about some red flags you may come across when doing your research. The internet is full of what I like to call “peptide pirates.” These are websites that sell cheap peptides labeled “for research only.” They might even look legit, but here's the thing, there's no regulation, no guarantee of purity or potency, and no support during your peptide therapy journey. Low cost and hidden fees Keep in mind that peptides are often expensive due to several factors. They require complex, specialized manufacturing processes, which include synthesis and purification to ensure quality and purity. Additionally, high-quality peptides are typically produced in small batches by licensed compounding pharmacies or peptide manufacturers, which increases costs. The research and development and regulatory compliance required to ensure their safety and efficacy also contribute to the higher price point.  If the prices from online peptide providers/clinics seem unusually low or too good to be true, there's a high likelihood that the products are either compromised, unregulated, or not what they claim to be. And while we're on the topic of cost, I shouldn't forget to mention hidden fees. You know, the sneaky little charges that pop up after you've been lured in by the words “free consultation.” When you book that initial appointment thinking, “Okay, great. I'll get expert advice, ask a few questions, and figure out if peptide therapy is right for me.” But then what happens? What if you've got more questions after the appointment—maybe you're dealing with side effects, started a new medication and want to be sure there aren't any interactions, or your symptoms have shifted and you're thinking about adjusting your dosage. And just like that, your “free” consultation suddenly comes with a consult price tag. I've personally seen clinics charge $50 just to email a follow-up question or do a “dosage review”. And don't get me started on the “lab interpretation fees.” You either pay for your bloodwork or labs are included, but then they charge you again just to tell you what your results mean.  Cold-chain And lastly, let's not forget that peptides are delicate compounds that require specific storage conditions. Certain peptide providers may not store or ship peptides correctly, affecting their potency and stability. As a general rule, for long-term storage, peptides should be kept frozen in their lyophilized (powder) form to preserve stability. Once reconstituted, most peptides should be stored in the refrigerator and used within the recommended timeframe, typically 2–8 weeks depending on the peptide and diluents used. It's important to avoid repeatedly freezing and thawing, as this can degrade the peptide structure and reduce its effectiveness.  Recap Do your homework. Research providers in your area. Look for peptide clinics or functional or integrative clinics with peptide experience. Ask smart questions. Where do they source peptides? Are the peptides made in a cGMP, FDA-registered facility? What's their follow-up protocol? How do they store and ship their peptides? Trust your gut—and the science. If something feels off, it probably is. Safe peptide therapy is always grounded in evidence and ethical practice. Your health isn't something to gamble with. Peptides can be powerful tools—but only from a trusted source and with guidance. Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  Have a happy, healthy week!

Join JACC Editor in Chief Harlan Krumholz, MD, SM, as he speaks about this ACC.25 presentation published in JACC. This fascinating study by Rohan Khera et al independently analyzed patient-level data from the SURMOUNT trials of tirzepatide for obesity. The study revealed striking individual variability in weight loss and metabolic response, even to a highly effective therapy—an insight powerfully illustrated through waterfall plots. Reviewers praised the transparent, sponsor-independent approach and the study's contribution to precision medicine, though they noted it was descriptive rather than predictive, underscoring the need for future research to identify what drives differential treatment response.

Study Link: http://biorxiv.org/content/10.1101/2025.04.17.649402v1.full.pdfGet My Book On Amazon: https://a.co/d/avbaV48Download The Peptide Cheat Sheet: https://peptidecheatsheet.carrd.co/Download The Bioregulator Cheat Sheet: https://bioregulatorcheatsheet.carrd.co/

Tirzepatide is more effective for weight loss than semaglutide.Cost-effectiveness is crucial in prescribing weight loss medications.Patients with severe obesity should receive more expensive medications for better outcomes.Both medications show significant benefits for obesity-related conditions.Long-term studies indicate sustained weight loss with both drugs.Gender differences affect weight loss outcomes with these medications.Safety profiles show tirzepatide may be better tolerated than semaglutide.The need for affordable drug pricing is emphasized.Clinical benefits extend beyond weight loss to include metabolic health.Future studies are needed to confirm cardiovascular benefits of tirzepatide.Click here to see the studyClick here to join Dr. Spencer's new online clinic

CBS News MoneyWatch correspondent Kelly O'Grady breaks down what to know about the potential financial impact to American consumers after the U.S. and China agreed to temporarily ease tariffs. Music superstar Taylor Swift has been subpoenaed in the ongoing legal dispute between Blake Lively and Justin Baldoni over allegations surrounding the making of their 2024 film "It Ends with Us."  A new study from the New England Journal of Medicine compares two weight loss drugs, Tirzepatide and Semaglutide. CBS News medical contributor Dr. Celine Gounder breaks down the findings. Nicole Scherzinger is making her Broadway debut in the stripped down, modern revival of "Sunset Blvd." She talks with "CBS Mornings" about the show, taking on the role and her first Tony nomination. In an exclusive "Begnaud's America" interview, CBS News contributor David Begnaud speaks with Gus Waltz, the son of Minnesota Gov. Tim Walz, who stole the spotlight during the 2024 Democratic National Convention. He's opening up about that moment and a learning disorder that is often misunderstood. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Os medicamentos injetáveis para emagrecimento, conhecidos como “canetas emagrecedoras”, incluindo Ozempic, Wegovy, Saxenda, Mounjaro e similares vinham sendo vendidos livremente no Brasil, sem a necessidade de prescrição médica. Mas isso vai mudar.A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou uma nova regra para a venda desses medicamentos, que só poderá ser feita mediante apresentação de receita médica em duas vias, sendo que uma delas ficará retida na farmácia - procedimento semelhante ao já adotado para antibióticos.Neste episódio, conversamos sobre as indicações desses medicamentos, seus efeitos colaterais e a importância do acompanhamento médico para o uso correto.Links relacionados:Tirzepatide as Compared with Semaglutide for the Treatment of ObesityComida Sem Filtro #88 – Injetáveis Para EmagrecerComida Sem Filtro #146 – Ozempic: Como Evitar O Reganho De Peso?Comida Sem Filtro #125 – Efeito Ozempic Na Indústria De AlimentosEstamos no Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Souto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sari Fontana⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Para ser avisado sobre cada novo episódio e receber os links das matérias mencionadas e as referências bibliográficas por e-mail, cadastre-se gratuitamente em ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drsouto.com.br/podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Adquira seu livro - UMA DIETA ALÉM DA MODA: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (também na versão Kindle)"Dance of the Sugar Plum Fairy"Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://creativecommons.org/licenses/by/3.0/⁠

Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine. Find our substack and all promotional links here: https://linktr.ee/manonthemounjaro

In this podcast, Dr. Valentin Fuster reviews findings from the SUMMIT trial, which examined how tirzepatide impacts patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD). The study revealed that while tirzepatide improved cardiovascular outcomes and slightly boosted kidney function, the benefits in CKD patients may stem from mechanisms beyond glomerular filtration alone.

腸泌素藥物如 Semaglutide、Tirzepatide 可以絕佳地控制血糖，更有驚人的減重效果，推出後風靡全球，有長達三年的時間被美國 FDA 認定為供不應求。除了糖尿病、減重效果之外，這些腸泌素藥物亦對大量重要疾病有潛在的治療效果（尚待臨床試驗證實），堪稱當代神藥。Tirzepatide 供應商禮來 (Eli Lilly) 因此躍升世界市值最高藥廠，諾和諾德 (Novo Nordisk) 也因 Semaglutide 一度成為歐洲最有價值的公司。 本集節目邀請到新陳代謝科醫師黃峻偉醫師，他同時是專欄《糖尿病筆記》作者。黃醫師與我們介紹糖尿病藥物、腸泌素的歷史延革，講解為什麼腸泌素藥物能有絕佳的減重表現，也討論這些藥物的巨大影響力。  

It seems like we all have patients taking Semaglutide or Tirzepatide and in this episode Tom Viola breaks down the things we need to know. How does it act? What should we be on the look our for? What oral/systemic manifestations might there be? Be sure to give this short episode a listen! Resources: Be sure to reach out to him if you have any questions by emailing TomViola@tomviola.com, visit his website TomViola.com or check out his social media - @pharmacologydeclassified

When it comes to pharmacy benefits, no topics make headlines like GLP-1s and weight loss programs. On this episode of HR Benecast,  Dr. Lia Rodriguez and Erin Bacon from CVS Health share what makes a clinical weight loss program really work. Listen to hear the latest obesity stats, obesity's link to other chronic conditions, the importance of lifestyle changes and more. 

It seems like we all have patients taking Semaglutide or Tirzepatide and in this episode Tom Viola breaks down the things we need to know. How does it act? What should we be on the look our for? What oral/systemic manifestations might there be? Be sure to give this short episode a listen! Resources: Be sure to reach out to him if you have any questions by emailing TomViola@tomviola.com, visit his website TomViola.com or check out his social media - @pharmacologydeclassified

In this first part of a two-part series, Dr. Saluja and Kane unpack how GLP-1 and GIP medications, including Ozempic, Wegovy, and Mounjaro, are reshaping not just metabolism, but also facial structure, leading to what's now known as "Ozempic Face." In this episode, they explore what GLP-1 receptor agonists and GIP agonists are, how rapid fat loss affects skin, collagen, and volume, and introduce key strategies that can be done at home from a nutritional perspective to support collagen health and overall facial balance. Join them as they break down the science and lay the foundation for more advanced treatment approaches discussed in Part Two. Thank you for your listenership!

Send us a textWelcome back Rounds Table Listeners! We are back today with a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the role of tirzepatide in weight reduction and diabetes prevention in persons with obesity. Here we go!Tirzepatide for Obesity Treatment and Diabetes Prevention (0:00 – 10:24).The Good Stuff:We've launched qMonthly, a monthly blog highlighting headliners and hidden gem trials published each month. Check it out here! (10:25 - 11:23)Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

So, you've heard the rumors—“GLP-1s destroy your muscle!” But… is that actually true? Think again. Today, we're setting the record straight. If you're serious about real, healthy weight loss—and actually keeping your strength for the long haul—this episode is a must. We're diving into a long-overdue conversation about GLP-1 medications, metabolism, body composition, and what's really happening to your muscle mass on these meds. Because weight loss isn't just about the scale—it's about how you lose it. Let's get into it. Quick Basics — What Are GLP-1 and GIP/GLP-1 Medications? Let's start at ground zero. GLP-1 medications — like semaglutide (Wegovy and Ozempic) — are game-changers for weight loss and diabetes. They work by mimicking gut hormones that regulate appetite, blood sugar, and insulin release. GLP-1 (glucagon-like peptide 1) slows down how fast your stomach empties, helps your body respond better to insulin, and most importantly — makes you feel fuller, longer. Tirzepatide (Mounjaro and Zepbound), also hits GIP receptors — that's glucose-dependent insulinotropic polypeptide — lending to more blood sugar regulation in some people. What Happens to Your Body During Weight Loss? No matter how you lose weight — whether it's from keto, bariatric surgery, or GLP-1 meds — your body isn't just burning fat. It's normal to lose a mix of fat mass and lean mass, which includes muscle, bone, and organ tissue. But the goal with any good weight loss plan is to maximize fat loss and minimize muscle loss. The Myth: “GLP-1s Make You Lose All Your Muscle” Here's the truth: GLP-1 medications do NOT inherently destroy your muscle mass. In fact, clinical studies have shown that GLP-1 medications, like semaglutide, have osteoblastic effects, meaning they can stimulate the activity of osteoblasts, the cells responsible for bone formation. This can potentially help improve bone density and support bone health. While the primary role of GLP-1 medications is to aid in weight loss and improve blood sugar control, these osteoblastic effects may offer additional benefits, especially in individuals at risk for osteoporosis or bone loss. If you see muscle loss during GLP-1 therapy, it's because of rapid overall weight loss and a lack of resistance training and protein — not because the medication is wasting your muscle. It's the same thing we see in ANY rapid weight loss — if you don't stimulate your muscles and feed them the right building blocks, your body gets rid of them because it thinks you don't need them. Muscle is metabolically expensive. Your body is smart — if it thinks you're not using muscle, it's going to save energy and dump it. That's biology — not the medication. Why Protein and Resistance Training Are Non-Negotiable If you're on a GLP-1, your appetite is lower — which is great for fat loss, but it means you could accidentally under-eat protein if you're not paying attention. Protein is literally the raw material your body uses to maintain and build muscle. Protein also helps build and repair tissues and is essential for producing enzymes, hormones, and maintaining a healthy immune system. Without enough, your body will start to break down lean tissue to make up the difference. And without resistance training (e.g., bodyweight exercises), your body assumes you don't need the muscle anymore. Use it or lose it. How to Protect (and Even Build) Muscle on GLP-1s Here's the simple formula: Prioritize protein: Aim for at least 0.8 to 1 grams per pound of body weight per day. Some need even more during active fat loss. Strength train 2–4 times a week: Focus on compound movements — think squats, deadlifts, presses, pulls, push ups, lunges, planks, and wall sits. Don't fear the scale: Remember that as you lose fat and build muscle, the number might not drop as fast — but your body composition is improving (e.g., reduced body fat, more defined muscles, improved waist circumference, increased energy and strength, and don't forget improved cardiovascular health). Think long-term: It's not just about losing weight — it's about keeping a strong, healthy, metabolically active body. THIS is what helps maintain weight loss. Making sustainable lifestyle changes can be challenging, but they are the most important choice you can make when it comes to losing weight and improving your metabolism in the long run. The goal isn't just weight loss — it's fat loss while preserving and strengthening lean mass. It's important to remember that GLP-1s are a powerful tool, but they aren't a magic. You still have to partner with your body — feed it well, move it wisely, and respect the incredible machine it is. Strong, lean, metabolically active — that's the future we're building, not just smaller bodies. Thanks again for listening to The Peptide Podcast. If this episode helped you rethink your game plan, do me a favor — share it with someone who's starting their GLP-1 journey. And as always, have a happy healthy week! Thanks for listening to The Peptide Podcast. If you found this episode helpful, please follow or leave a review. And if there's a topic you'd like to hear more about, feel free to reach out—we'd love to hear from you. As always, have a happy, healthy week! We're huge advocates of elevating your health game with nutrition, supplements, and vitamins. Whether it's a daily boost or targeted support, we trust and use Momentous products to supercharge our wellness journey.  Momentous only uses the highest-quality ingredients, and every single product is rigorously tested by independent third parties to ensure their products deliver on their promise to bring you the best supplements on the market.

Drs Carol H. Wysham and Christopher M. Kramer discuss heart failure and type 2 diabetes, and the role of incretin therapies in the management of HFpEF. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002048. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources The Incidence of Congestive Heart Failure in Type 2 Diabetes: An Update https://pubmed.ncbi.nlm.nih.gov/15277411/ Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease https://pubmed.ncbi.nlm.nih.gov/34601960/ Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update https://pubmed.ncbi.nlm.nih.gov/31167558/ Insulin Resistance and Hyperinsulinaemia in Diabetic Cardiomyopathy https://pubmed.ncbi.nlm.nih.gov/26678809/ Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024 https://pubmed.ncbi.nlm.nih.gov/38078592/ The Paradox of Low BNP Levels in Obesity https://pubmed.ncbi.nlm.nih.gov/21523383 Tirzepatide for Heart Failure With Preserved Ejection Fraction and Obesity https://pubmed.ncbi.nlm.nih.gov/39555826/ Cardiovascular Effects of Incretin-Based Therapies: Integrating Mechanisms With Cardiovascular Outcome Trials https://pubmed.ncbi.nlm.nih.gov/35050311/ Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF https://pubmed.ncbi.nlm.nih.gov/38294187/ Heart Failure With Preserved Ejection Fraction: Mechanisms and Treatment Strategies https://pubmed.ncbi.nlm.nih.gov/34379445/ Obesity and Heart Failure With Preserved Ejection Fraction: New Insights and Pathophysiological Targets https://pubmed.ncbi.nlm.nih.gov/35880317/ Epidemiology of Heart Failure in Diabetes: A Disease in Disguise https://pubmed.ncbi.nlm.nih.gov/38334818/ Semaglutide in Patients With Heart Failure With Preserved Ejection Fraction and Obesity https://pubmed.ncbi.nlm.nih.gov/37622681/ Mechanisms of Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/37674356/ Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/39225278/ Effects of Tirzepatide on Circulatory Overload and End-Organ Damage in Heart Failure With Preserved Ejection Fraction and Obesity: A Secondary Analysis of the SUMMIT Trial https://pubmed.ncbi.nlm.nih.gov/39551891/ Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, a Preserved Ejection Fraction, and Obesity https://pubmed.ncbi.nlm.nih.gov/39556714/ Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy https://pubmed.ncbi.nlm.nih.gov/39566869/6 Spironolactone for Heart Failure With Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/24716680/

EP. 207: A new study on tirzepatide just dropped, and some obesity experts claim it confirms that the drug works only by reducing calories. After reading the full paper myself, I've got a different take. In this episode, I unpack what the study actually shows—like how tirzepatide increases fat oxidation without impacting metabolic adaptation—and why the “calories in, calories out” story doesn't tell the whole truth. There's more going on here, and you deserve the full picture. Topics Covered: Does tirzepatide help with metabolic health beyond calorie restriction leading to weight loss? How does it affect metabolic adaptation in people with obesity? Can it boost fat oxidation? Is the “calories in, calories out” model outdated for GLP-1s? What does this mean for long-term metabolic health? Sponsored By: Qualia | Go to qualialife.com/DRTYNA for up to 50% off your purchase and use code DRTYNA for an additional 15% Sundays | As a Listener of The Dr Tyna Show, you can Get 40% off your first order of Sundays. Go to sundaysfordogs.com/DRTYNA and use code DRTYNA at checkout. Liver Love | Go to https://store.drtyna.com/products/liverlove Use code DRTYNASHOW at checkout to save. LMNT | Get your free Sample Pack with any LMNT purchase at drinkLMNT.com/drtyna BIOptimizers | For an exclusive offer on MassZymes go to Bioptimizers.com/DRTYNA and use promo code DRTYNA On This Episode We Cover:  00:00:00 – Introduction  00:02:44 – Obesity study on GLP1s and weight loss 00:04:21 – Calories in vs. calories out 00:05:44 – Resting metabolic rate 00:09:25 – Metabolic adaptation during dieting 00:12:11 – Tirzepatide dosing in clinical studies 00:15:49 – Maintaining weight loss 00:18:15 – GLP1s &  increased fat oxidation 00:19:14 – GLP1 microdosing myths 00:26:06 – Metabolic rate drops vs. metabolic improvements 00:29:51 – Lessons from the Biggest Loser study 00:34:20 – Study Comparation 00:35:25 – Weight loss, inflammation, and aging 00:36:35 – Health autonomy  00:40:23 – Caloric restriction and the CALERIE study Studies Mentioned:  Tirzepatide Did Not Impact Metabolic Adaptation In People With Obesity, But Increased Fat Oxidation Persistent Metabolic Adaptation 6 Years After The Biggest Loser Competition Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy (CALERIE) Show Links GLP-1s Done Right University Dr. Tyna's Strength Corner Metabolic Revamp Toolkit + Masterclass Further Listening:  GLP1s Uncovered (Free Class) EP. 202 | The Fight for Affordable GLP1s & the Truth About Big Pharma | Dave Knapp Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Eli Lilly will start a lcinical trial for tirzepatide for people with type 1 diabetes, more details on Dexcom's 15 day G7 sensor, Ozepmic pill form tested, type 5 diabetes identified and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week.. Eli Lilly takes the first steps toward getting tirzepatide approved for people with type 1 diabetes. Tirzepatide is sold under the brand names Mounjaro for type 2 and Zepbound for obesity. The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or are overweight. Participation in the study will last about 49 weeks. Official Title A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight This is a big deal because, even though many people with type 1 are able to get a prescription for tirzepatide, it's not approved for T1D and so insurers won't usually cover it.   https://clinicaltrials.gov/study/NCT06914895 XX The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there's little information on the drugs' safety and effectiveness for the condition. The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can't make enough of their own. Drugmakers feared that using the GLP-1 medications with insulin might raise the chance of dangerously low blood sugar events, or hypoglycemia, and were unwilling to take the risk of studying them in people with type 1.   For the study, which was published last month in the journal Diabetes, Obesity, and Metabolism, researchers at Johns Hopkins University reviewed the medical records of more than 200,000 people with type 1 diabetes from 2008 to 2023. They grouped the data in three-year periods, starting with October 2008 to September 2011 and ending with October 2020 to September 2023. GLP-1 medication use spiked, as well. Among adults with the highest category of obesity, about 4% used GLP-1 medications in 2008, and 33% did by 2023 – an 800% increase. But these are anecdotal reports and may not reflect instances in which people have side effects or complications like low blood sugar, which can be life-threatening. But Shin says what's really needed is information from randomized, double-blinded studies, in which participants are followed forward in time and given either a drug or a placebo. https://www.cnn.com/2025/04/09/health/glp-1-type-1-diabetes-study/index.html   XX Later this month the FDA will conduct a final meeting regarding a new, investigational compound (sotagliflozin) soda-GLIFF-a-zin that has been shown to Improve QoL and Reduce Long-term Complications for people with type 1 diabetes (T1D). The patient advocacy group Taking Control of Your Diabetes (TCOYD.org) is working to inform the T1D community about sotagliflozin - and to encourage people to sign a Change.org petition directed towards FDA.  Last fall, the FDA declined to approve sotagliflozin due to concerns about a potential increased risk of diabetic ketoacidosis (DKA), despite this being a condition that people with T1D on insulin face and manage daily. While TCOYD respects FDA's caution, the group stands by T1D patients and their physicians who, as a team, balance risks and benefits every day. https://tcoyd.org/petition/ XX Dexcom receives FDA approval for it's G7 with 15 day wear. We have an interview with Chief Operating Officer Jake Leach coming up on Tuesday – we talk about the planned roll out of this sensor, what else has changed, and the fine print in the press release – it says    “A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days.   https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System/default.aspx?utm_source=www.diabetech.info&utm_medium=referral&utm_campaign=dexcom-g7-15-day-sensor-gets-fda-cleared-but-will-it-actually-last-that-long   XX Glucotrack is joining something called  FORGETDIABETES bionic pancreas initiative, - this is an European Union project that aims to develop a long-term automated insulin delivery system for type 1 diabetes patients. Glucotrack's Continuous Blood Glucose Monitor (CBGM) will be integrated into the system to provide real-time glucose readings. The initiative's goal is to create a bionic invisible pancreas that eliminates the need for therapeutic actions and reduces psychological burden.   The architecture of BIP encompasses a ground-breaking, lifelong lasting implanted ip glucose nanosensor; a radically novel ip hormone delivery pump, with unique non-invasive hormone refill with a magnetic docking pill and non-invasive wireless battery recharge; an intelligent closed-loop hormone dosing algorithm, optimized for ip sensing and delivery, individualized, adaptive and equipped with advanced self-diagnostic algorithms.     Pump refilling through a weekly oral recyclable drug pill will free T1D subjects from the burden of pain and awkward daily measurement and treatment actions. Wireless power transfer and data transmission to cloud-based data management system round-up to a revolutionary treatment device for this incurable chronic disease. key feature of BIP is to be fully-implantable and life-long lasting thanks to novel biocompatible and immune-optimized coatings guaranteeing long-term safety and stability https://www.stocktitan.net/news/GCTK/glucotrack-to-participate-in-forgetdiabetes-a-prominent-european-cjjldjb0dq7h.html XX A newly recognised form of diabetes, called Type 5, was announced this week at the World Congress of Diabetes 2025. A global task force will investigate this less-understood condition, which differs from Type 1 and Type 2 diabetes. Type 5 diabetes affects people who are underweight, lack a family history of diabetes and do not show the typical symptoms of Type 1 or Type 2 diabetes. The condition was first observed in the 1960s and referred to as J-type diabetes, after being detected in Jamaica. It was classified by the World Health Organisation in 1985, but removed in 1998 due to lack of physiological evidence. At the time, experts believed it to be a misdiagnosed case of Type 1 or 2 diabetes. New research has since confirmed that Type 5 is different. https://economictimes.indiatimes.com/news/new-updates/a-new-type-of-diabetes-has-been-found-by-scientists-and-it-doesnt-show-the-typical-symptoms-of-type-1-or-type-2/articleshow/120276658.cms?from=mdr   XX Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. A new clinical trial, co-led by endocrinologist and diabetes specialist John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine, has demonstrated that the oral form of semaglutide significantly lowers the risk of cardiovascular events in individuals with type 2 diabetes, atherosclerotic cardiovascular disease, and/or chronic kidney disease. Results from the rather large, international trial were published in the New England Journal of Medicine and presented at the American College of Cardiology's Annual Scientific Session & Expo in Chicago, Illinois.     The effect of oral semaglutide on cardiovascular outcomes was consistent with other clinical trials involving injectable semaglutide, but more trials are needed to determine if one method may be more effective than the other at reducing major cardiovascular events. https://scitechdaily.com/new-pill-form-of-semaglutide-shows-major-benefits-for-people-with-diabetes/ XX April 14 (UPI) -- The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States. Novo Nordisk, the Danish-headquartered manufacturer, informed the FDA on April 3 that counterfeit 1-milligram injections of semaglutide were being distributed outside its authorized supply chain. The FDA and Novo Nordisk are testing the fake products to identify whether they're safe. Patients are asked to obtain Ozempic with a valid prescription through state-licensed pharmacies and check the product for any signs of counterfeiting. People in possession of the fake product are urged to call Novo Nordisk customer care at 800-727-6500 Monday through Friday from 8:30 a.m. to 6 p.m. EDT and report it to the FDA's criminal activity division's website. Side effects can be reported to FDA's MedWatch Safety Information and Adverse Event Reporting Program (800-FDA-1088 or www.fda.gov/medwatch) as well as to Novo Nordisk, at 800-727-6500. https://www.upi.com/Health_News/2025/04/14/FDA-fake-Ozempic-drugs-Novo-Nordisk/6841744666854/ XX Can a digital lifestyle modification program reduce diabetes risk? A new study shows that the lifestyle intervention significantly reduced 10-year diabetes risk among prediabetics by nearly 46% and increased the diabetes remission rate, highlighting the importance of lifestyle changes. However, the study was not a randomized trial, and participation in the lifestyle intervention was voluntary, which may introduce selection bias. The study evaluated 133,764 adults, categorizing them as diabetic (7.5%), prediabetic (36.2%), and healthy (56.3%), based on fasting glucose and HbA1c levels. https://www.news-medical.net/news/20250414/Digital-lifestyle-program-cuts-diabetes-risk-by-4625-in-prediabetics-study-of-130k2b-adults-reveals.aspx XX Chrissy Teigan is speaking out about her son's type 1 diagnosis – teaming up with Sanofi to encourage people to screen early for Type 1 diabetes.   Teigen got a crash course in the risks of undiagnosed Type 1 diabetes when her 6-year-old son, Miles, was hospitalized with complications of the autoimmune disease last year. The family knew nothing about Type 1 diabetes when Miles was diagnosed during an unexpected medical emergency, Teigen said in a Tuesday announcement. “We were confused and scared when Miles was first diagnosed,” she said in a statement. “There is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!”   Teigen shared her family's story in a two-minute video on ScreenForType1.com, a Sanofi website that discusses how to get screened for the condition. Miles' diagnosis made Teigen feel like she “went from a mom to a doctor overnight,” she said. That experience is why Teigen said she is “begging you: Do this one thing, and screen yourself and your family for Type 1 diabetes.” https://www.fiercepharma.com/marketing/sanofi-signs-chrissy-teigen-diabetes-screening-campaign XX Dr. Richard Bernstein – best known for his advocacy around low carb diets for people with diabetes – died this week at the age of 90. Born in 1934 in Brooklyn, New York, he was diagnosed with type 1 at age 12. In the 1970s he adapted a blood glucose monitor for home use and helped pioneer home glucose monitoring. He published multiple books on Diabetes including the #1 selling Diabetes book on Amazon.Com “Dr. Bernstein's Diabetes Solution: A Complete Guide to Achieving Normal Blood Sugars” and “Diabetes Type II: Living a Long, Healthy Life Through Blood Sugar Normalization”.  He practiced and saw patients right up until his death.

**Dr. Lisa Faast shares important news about tirzepatide compounding. After a shortage, the FDA reversed its decision and now allows pharmacies to compound and sell tirzepatide again. She covers the latest updates, suppliers like Lone Star Pharmaceuticals, BPI Labs, and PQ Pharma, and tips on staying compliant with state boards. Stay informed by joining the APC Alliance.** **Show Notes:** 1. **FDA Reversal on Tirzepatide Compounding** [0:00] 2. **Clarification from the FDA ** [2:51] 3. **Availability and Cost of Tirzepatide ** [5:09] 4. **State Regulations and Documentation** [6:31] 5. **Final Thoughts and Resources** [7:02] **Websites Mentioned: https://lonestarpharmaceuticals.com/ https://bpilabs.com/ https://www.pqpharmacy.com/s/ https://diversifyrx.com/weekly-awesomeness-newsletter/ https://www.drlisafaast.com/ ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**

SKIN & WELLNESS APPBLOGMy Epic Semaglutide Taper Journey! Astonishing Ozempic Weight Loss Transformation!Ozempic weight loss before and after. I used semaglutide for six months in 2023 to lose 25 lbs. This is my generic Ozempic dosage, how I tapered off, and how much weight I lost over six months.In this video, Ozempic weight loss before and after I share my Ozempic semaglutide dosage and taper calendar, plus a ton of photos and what I'm doing after using Ozempic. This is my semaglutide taper experience. If you can relate to any of this please tell me and we connect over this experience.Mommy Makeover Playlist: https://urlgeni.us/youtube/playlist/MMOplaylistCarnivore 1 Year Blood Work Results https://urlgeni.us/youtube/Carnivore1yearSemaglutide is the peptide in the name-brand Ozempic weight loss pen.Other GLP-1 are Liraglutide and Tirzepatide.SKIN & WELLNESS APP: ⁠https://urlgeni.us/AppInstall⁠NEWSLETTER ⁠https://urlgeni.us/NATURALKAOSNEWSLETTER⁠ASK IT any question you would ask me: ⁠https://mindos.com/share/265992794323804160⁠AMAZON LOCATIONSUS FACE SKINCARE ⁠https://www.amazon.com/shop/naturalkaos⁠CANADA FACE SKINCARE ⁠https://www.amazon.ca/shop/naturalkaos⁠UK FACE SKINCARE ⁠https://www.amazon.co.uk/shop/naturalkaos⁠SKINCARE SHOPSSHOP MY SHELF Products & Devices ⁠https://urlgeni.us/ShopMyShelf⁠ACID PEELS: ⁠https://www.makeupartistschoice.com⁠ KAOS20DR PEN USA CODE: KAOS15  ⁠https://drpen-usa.com⁠WHAT I USE TO CREATEMUSIC: Epidemic Sound ⁠https://www.epidemicsound.com/referral/qt9tsb/⁠FILMING EQUIPMENT: ⁠https://bit.ly/MyFilmingEquip⁠SOCIAL     MEDIAWEBSITE ⁠https://urlgeni.us/NKsiteAndblog⁠TIKTOK ⁠https://urlgeni.us/tiktok/NKskin⁠INSTAGRAM ⁠https://urlgeni.us/instagram/NKskin⁠FB PAGE ⁠https://urlgeni.us/facebook/NKFBpage⁠#weightlossjourney #ozempic #semaglutide #naturalkaos

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes. Overall, their findings show a significant uptick in tirzepatide dispensations, alongside other glucose- and weight-lowering medications, including semaglutide.

SKIN & WELLNESS APPBLOGOzempic weight loss before and after vs Gastric Sleeve: Did Semaglutide Ruin My Hair? This is my Ozempic weight loss before and after experience with Semaglutide, aka the magic peptide that makes everyone skinny in three months. The Semaglutide peptide is incredible, and I believe it, along with Tirzepatide, will replace the gastric sleeve weight loss surgery.I was married in 2007 at 25 and weighed 120 lbs. I blew up to 192 lbs the following year when pregnant with our first baby. I had four boys back to back. In 2017, I decided to undergo the single gastric sleeve in Mexico, where it's quick and straightforward to qualify and pay cash. That surgery was only $5,000, which is crazy cheap.After dropping to my marriage weight goal of 120 lbs, I elected in 2023 to have the mommy makeover surgery. The entire playlist is HEREAfter my surgery, I got a prescription for Semaglutide, aka Ozempic, and started using it on July 1, 2023. I went from 125 lbs to 110 lbs. This quick weight drop, along with its significant percentage of my overall body, caused metabolic stress that has resulted in my hair falling out. I am experiencing Telogen Effluvium, which is a hair shed that you will notice. Three months following your quick weight drop will result in a hair shed. The severity of the stress will only be recognized by your hair months later.MEXICO HOSPITALUSING TO RE-GROW HAIR:Liquid Vitamin Smarty Pants Protein Shake My Scale HF Hair Wand NEWSLETTER ⁠https://urlgeni.us/NATURALKAOSNEWSLETTER⁠ASK IT any question you would ask me: ⁠https://mindos.com/share/265992794323804160⁠AMAZON LOCATIONSUS FACE SKINCARE ⁠https://www.amazon.com/shop/naturalkaos⁠CANADA FACE SKINCARE ⁠https://www.amazon.ca/shop/naturalkaos⁠UK FACE SKINCARE ⁠https://www.amazon.co.uk/shop/naturalkaos⁠SKINCARE SHOPSSHOP MY SHELF Products & Devices ⁠https://urlgeni.us/ShopMyShelf⁠ACID PEELS: ⁠https://www.makeupartistschoice.com⁠ KAOS20DR PEN USA CODE: KAOS15  ⁠https://drpen-usa.com⁠WHAT I USE TO CREATEMUSIC: Epidemic Sound ⁠https://www.epidemicsound.com/referral/qt9tsb/⁠FILMING EQUIPMENT: ⁠https://bit.ly/MyFilmingEquip⁠SOCIAL     MEDIAWEBSITE ⁠https://urlgeni.us/NKsiteAndblog⁠TIKTOK ⁠https://urlgeni.us/tiktok/NKskin⁠INSTAGRAM ⁠https://urlgeni.us/instagram/NKskin⁠FB PAGE ⁠https://urlgeni.us/facebook/NKFBpage⁠#weightlossjourney #ozempic #semaglutide #naturalkaos #skincareuncensored

West Wellness and Longevity LinksAre you ready to make change but don't know where to start. Book a free 30 min consultation here.https://www.westwellnessatx.com/get-started Purchase the highest quality Hydrogen Water tabs on the market! Just the code WESTWELL or 10% off your orders! https://drinkh2tab.com/?ref=WESTWELLPurchase they highest medical grade quality GHK-Cu topical serum at Vitali Skin care https://www.vitaliskincare.com/?ref=undrarqlThis is the most versatile Red Light Therapy Device on the Market and it works-The NuShape Wrap! Use this link to get $50 off your order https://www.nushape.com/TARA88932Get all the benefits of grounding while working or watching TV use this link to get a discount at checkout https://hoogahealth.com/?ref=TARAWESTCalocurb, clinically proven to boost GLP hormones naturally, get all the benefits of the skinny shot with this supplement! https://www.calocurb.com?sca_ref=6404263.tgXaSY3HQx use the code TARA10 and get 10% off your orders.MIC + B-12 injections for energy, hormone balance, insulin sensitivity , mood and more. Got to https://www.tryeden.com/Finally a FDA approved CGM (constant glucose monitor) for non-diabetics! https://www.stelo.com/West Wellness and Longevity LinksAre you ready to make change but don't know where to start. Book a free 30 min consultation here.https://www.westwellnessatx.com/get-started Purchase they highest medical grade quality GHK-Cu topical serum at Vitali Skin care https://www.vitaliskincare.com/?ref=undrarqlThis is the most versatile Red Light Therapy Device on the Market and it works-The NuShape Wrap! Use this link to get $50 off your order https://www.nushape.com/TARA88932Get all the benefits of grounding while working or watching TV use this link to get a discount at checkout https://hoogahealth.com/?ref=TARAWESTPurchase the highest quality Hydrogen Water tabs on the market! Just the code WESTWELL or 10% off your orders! https://drinkh2tab.com/?ref=WESTWELLHave questions? Feel free to reach out to me at: tarawest@westwellnessatx.com • • Follow me on instagram @westwellnessatxIn this episode, I'm talking all about what happens when you stop taking GLP-1 meds like Tirzepatide or...

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog The newest miracle drug for weight loss is changing the lives of thousands of people who have battled obesity for extended periods of time….These GLP-1 medications are also treating or preventing the diseases that go with long term obesity: Diabetes, Heart Disease, Joint replacements, Arthritis, Sleep Apnea, and Alzheimer's Disease. Researchers are finding more indications every day for patients to take these weight loss medications. But like anything else there is no perfect answer to any problem.  Among the few side effects of this drug, the most frequent side effect is reflux, also called acid indigestion, or GERD (gastroesophageal reflux disease).  Often my patients don't even know what their diagnosis is, they just tell me about their symptoms. The symptoms of GERD include: Asthma symptoms A bad taste in the mouth Difficulty swallowing Dry, hacking, cough Chest pain after meals These symptoms are worse after a big meal, at bedtime, after spicy food, or dose related.  Most of my patients don't want to discontinue the GLP-1 inhibitors because they are finally losing weight!  We manage the GLP-1 side effect of GERD by decreasing dose of the medication and slowly increase the dose back to an effective level. We also offer lifestyle and dietary treatments before we offer prescription medication. Therefore, if reflux is not constant, and is not causing any lasting damage to the patient's esophagus, we can treat it with lifestyle changes and over the counter medication, to lower the stomach acid that is refluxing into the esophagus. The lifestyle changes patients can employ on their own are described below. Lifestyle changes needed to avoid or treat Gastric Reflux caused by GLP-1 agonists. What can you do to prevent and treat this side effect: Eat smaller meals: Large meals expand your stomach and put pressure on your lower esophageal sphincter (LES). Don't go to bed less than 2 hours after eating Avoid trigger foods see below Sleep on your left side Elevate the head of your bed Avoid tight clothing: Chew your food well– chew each bite for 20 seconds. Quit smoking: Smoking weakens your LES and makes your stomach more acidic. Stop drinking alcohol Chew (non-mint) sugar-free–gum  In addition to changing your active lifestyle, changing your diet is necessary as well. There are trigger foods to avoid minimizing your reflux symptoms.  tomato sauce and other tomato-based products high fat foods, such as fast food and greasy foods fried foods citrus fruit juices soda-diet and regular Caffeine Garlic onions mint of any kind milk based products My patients ask me, “So what can I eat?” …I admit I did take away some of the most exciting foods, however my patients ask me what they can eat so the list of foods that help avoid and treat GERD are listed below. High-fiber foods: vegetables, fruit, and whole grain bread. Alkaline foods. Foods fall somewhere along the pH scale (turns litmus paper blue). Drink alkalinized water (PH > 8) Ginger—fresh sushi Ginger from Asian food stores. Apple cider vinegar on salads and a Tablespoon in water every morning Lemon water—just squeeze a slice of lemon in your water. Coconut water Honey. Lean Protein including meat Low-Fat and Nonfat Dairy Products. Non-Citrus Fruits like apples, pears, bananas, and melons Vegetables like broccoli, Carrots, Corn, Cucumbers, Green Beans, Green peppers, Potatoes and Sweet potatoes   For my patients who take herbal and other supplements, the following is a list of the supplements that may decrease your symptoms of GERD. Chamomile Tea Licorice Marshmallow Slippery Elm Tablets Probiotics-Mega Brand Prebiotics-Mega Digestive Enzymes Aloe Vera Juice Baking Soda Magnesium glycinate What happens when you have made all the lifestyle changes you can and have lowered your GLP-1 dose or changed to a different type of GLP-1 Agonist, and you still have GERD? As a physician I prescribe medications to help my patients treat their GERD, however most of the medications have been placed over the counter so I can recommend them to my patients, and they can buy the medication without a script. The class of medication that treats GERD include Antacids, H2 Blocker, and Proton Pump Inhibitor.  Antacids neutralize stomach acid, but they typically only work for short periods. They are generally made of calcium. This type of medication is best used prn for symptom relief.  Side effects of antacids may include constipation and diarrhea. The second option for treatment of GERD is an H2 blocker. These drugs reduce the amount of acid the stomach releases. Eg. Pepcid, Tagamet, Gaviscon. Proton pump inhibitors (PPIs): These drugs are available by prescription from a healthcare provider, and now some doses are over the counter. PPIs help reduce the amount of acid the stomach makes.  They should be used for a two-week period only for severe attacks and then you should change to an H2 blocker or antacid. WHY stop a PPI after 2 weeks?   Omeprazole is an example of a PPI.  Theses medication kill the good bacteria in your intestines, change your breath and can affect how you absorb your nutrients. If you must take them chronically to treat and prevent the progression of damage to the esophagus. What if I did everything and GERD is still a problem: If your condition is severe, your doctor may recommend a consultation with a GI doctor for an endoscope or other diagnostic procedure.  In addition, you may have to hold your GLP-1 Agonist for a period of time while you treat your esophageal inflammation. Just as in all medical issues there are many ways to treat side effects of drugs. Your provider will prescribe the medication that she or he is most comfortable with. What next? So if you have reflux and are on a GLP-1 inhibitor, you may be advised to decrease your dose or switch to Tirzepatide medication (Mounjaro, Zepbound). There are many steps you can take before you need prescribed medication. Your doctor may even change your GLP-1 agonist prescription or refer you to a GI doctor, but before this is necessary you should try the lifestyle and dietary changes that I recommend in this Blog first. This side effect of GLP-1 agonists doesn't affect every patient and can be managed as you see above, however the lifestyle changes and dietary changes can only be done by you, so the ball is in your court!

In this month's Digital Health Download, Steve, Halle, and Michael take a deliberately optimistic look at key headlines in healthcare technology. From the impressive impact of AI scribing tools on physician satisfaction to encouraging survival rates among digital health unicorns from the ZIRP-era, the hosts highlights bright spots in an often challenging industry.We cover:

Claim your complimentary gift of my exclusive mini weight care guide today!Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)Struggling to find compounded versions of Semaglutide and Tirzepatide? You're not alone. As these medications become harder to access, many patients are left wondering, "What's next?"In this episode, we sit down with Joe Zucchi, a physician assistant, personal trainer, and clinical supervisor at Transition Medical Weight Loss in Salem, New Hampshire. Joe walks us through the current shortage of compounded medications, what's really going on behind the scenes, and why safe, FDA-approved alternatives are more important than ever. But it's not just about medication. We dive into why obesity isn't just about willpower, discussing how it's a complex issue that goes beyond simple behavior choices. Joe also sheds light on the issue with compounded GLP-1 medications and the risks involved. Plus, he shares practical tips on how to make exercise work for you, whether you're just getting started or looking to refine your routine.Joe's approach to weight management is unique, combining fitness, nutrition, medical treatments, and even an on-site marketplace stocked with healthy, portion-controlled foods. His clinic's well-rounded approach ensures that patients receive the support they need for long-term success, no matter where they are on their weight management journey.Tune in to hear Joe's expert insights and find out how to stay on track with your goals. Don't forget to listen to the full episode!Connect with Mr. Zucchi:Linkedin: Joseph Zucchi, PA-CX: JPZfitness Instagram: transitionweightlossConnect with me:Instagram: doctorfrancavillaFacebook: Help Your Patients Lose Weight with Dr. FrancavillaWebsite: Dr. Francavilla ShowYoutube: The Doctor Francavilla ShowGLP Strong: glpstrong.com

Watch Here : https://www.youtube.com/watch?v=2im1dhv11Ck Website: https://vigoroussteve.com/ Consultations: https://vigoroussteve.com/consultations/ eBooks: https://vigoroussteve.com/shop/ YouTube Channel: http://www.youtube.com/user/VigorousSteve/ Workout Clips Channel: https://www.youtube.com/channel/UCWi2zZJwmQ6Mqg92FW2JbiA Instagram: https://instagram.com/vigoroussteve/ TikTok: https://www.tiktok.com/@vigoroussteve Reddit: https://www.reddit.com/r/VigorousSteve/ PodBean: https://vigoroussteve.podbean.com/ Spotify: https://open.spotify.com/show/2wR0XWY00qLq9K7tlvJ000 Patreon: https://www.patreon.com/vigoroussteve

Dr. Jason Bloom is deeply invested in the future of facial aesthetics, teaching around the world and leading clinical research with top aesthetics companies to drive innovation in the field.  As the co-director of the Facial Plastic and Reconstructive Surgery Fellowship at the University of Pennsylvania, he works closely with residents at Temple University and Philadelphia College of Osteopathic Medicine.Dr. Bloom's new, 4,000-square-foot surgery center just outside downtown Philadelphia is a go-to destination for facial aesthetics. With an expert understanding of facial anatomy, he attracts patients from Philly, South Jersey, Delaware, and beyond.Learn more about Philadelphia facial plastic surgeon Dr. Jason BloomFollow Dr. Bloom on Instagram @drjbloomFollow Dr. Bloom's practice on Instagram @bloom.facial.plastics ABOUT MEET THE DOCTOR The purpose of the Meet the Doctor podcast is simple.  We want you to get to know your doctor before meeting them in person because you're making a life changing decision and time is scarce. The more you can learn about who your doctor is before you meet them, the better that first meeting will be. When you head into an important appointment more informed and better educated, you are able to have a richer, more specific conversation about the procedures and treatments you're interested in. There's no substitute for an in-person appointment, but we hope this comes close.Meet The Doctor is a production of The Axis. Made with love in Austin, Texas.Are you a doctor or do you know a doctor who'd like to be on the Meet the Doctor podcast?  Book a free 30 minute recording session at meetthedoctorpodcast.com.

This episode is full of tough love. The reality of your weight loss journey is that nobody is coming to save you. NOBODY! The eff bombs are flying. You've been warned!Irresistible Links

Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

When Karen couldn't shake that last 20 pounds, she considered liposuction. But between the cost and the downtime, it just didn't feel like the right fit for her busy life. That's when she decided to give weight loss medication a try.After surviving breast cancer, Karen struggled to lose weight. At 63, she is actively exploring San Diego, boating, and making the most of life, and she's thrilled that the skinny shot has her feeling more energized, confident, and ready to move.Beyond weight loss, Karen discovered some unexpected perks, like fewer alcohol cravings and an overall boost in her health.She shares all the NSVs (non-scale victories), her best tips for seeing results while feeling great, how she uses ChatGPT to find great recipes, and her experience with the Signature Skinny Shot program at LJCSC.LinksLearn more about the Signature Skinny Shot GLP-1 medical weight loss program at La Jolla Cosmetic Surgery CentreLearn more about the skinny shot and watch our video about getting started on our Signature Skinny Shot YouTube PlaylistLearn from the talented plastic surgeons inside La Jolla Cosmetic, the 20x winner of the Best of San Diego and global winner of the 2020 MyFaceMyBody Best Cosmetic/Plastic Surgery Practice.Join hostess Monique Ramsey as she takes you inside La Jolla Cosmetic Surgery Centre, where dreams become real. Featuring the unique expertise of San Diego's most loved plastic surgeons, this podcast covers the latest trends in aesthetic surgery, including breast augmentation, breast implant removal, tummy tuck, mommy makeover, labiaplasty, facelifts and rhinoplasty.La Jolla Cosmetic is located just off the I-5 San Diego Freeway at 9850 Genesee Ave, Suite 130 in the Ximed building on the Scripps Memorial Hospital campus.To learn more, go to LJCSC.com or follow the team on Instagram @LJCSCWatch the LJCSC Dream Team on YouTube @LaJollaCosmeticThe La Jolla Cosmetic Podcast is a production of The Axis: theaxis.io 

Join JACC Associate Editor Khurram Nasir, MBBS, FACC, and author Rohan Khera, MD, FACC, as they discuss the latest study on tirzepatide presented at ACC.25 and published in JACC. Tirzepatide, a dual GIP/GLP-1 receptor agonist, exerts pleiotropic effects on cardiometabolic health. This study evaluated its efficacy in improving cardiometabolic outcomes in individuals with T2D. An individual participant data meta-analysis was conducted, pooling data from seven Phase 3 RCTs comparing tirzepatide with placebo or standard antihyperglycemic agents. The study outcomes included cardiometabolic components of metabolic syndrome (MetS), elevated BMI, and MetS. Tirzepatide significantly reduced the odds of these abnormalities and effectively resolved MetS, with superior efficacy observed in younger individuals and those not on baseline SGLT2is. These findings support the potential of tirzepatide to improve cardiometabolic health in T2D.

**In this quick episode, Dr. Lisa Faast explains the FDA's recent decision about the tirzepatide shortage and what it means for pharmacies.** **Show Notes:** 1. **FDA Announcement on Turzepatide Shortage** [0:00] 2. **Impact on Compounding and Patient Care** [1:48] 3. **Strategies for Pharmacies to Increase Demand** [3:14] 4. **Final Thoughts and Call to Action** [5:02] Websites Mentioned: https://www.drlisafaast.com/ ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be a Part of the Pharmacy Podcast Network**

In this rare and exclusive interview, the chairman of the Outsourcing Facilities Association sits down with On The Pen to discuss the current landscape of compound tirzepatide. Www.503bs.org

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425 Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity.  Episode resource links: https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html https://emedicine.medscape.com/article/295807-overview Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... & Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... & US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950. https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/ Guest: Mariyan L. Montaque, DNP, FNP-BC  Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55______________________________________________________________________In this episode, we're diving into Ro's innovative approach to weight management with Dr. Steve Silvestro, Associate Director of Clinical Content & Education, and exploring why now is a critical time to discuss telehealth weight loss solutions. With the shortage of Tirzepatide and semaglutide behind us, patients may face more difficulty finding safe, regulated, compounded GLP-1 medications. Many may even consider turning to the black market to obtain research-grade GLP-1s, but it's important to understand the risks involved.Ro offers a regulated and safe alternative: Zepbound vials, which can be prescribed at almost the same cost as compounded tirzepatide, with the added benefit of medical oversight. Dr. Silvestro shares how Ro's personalized care model works to help patients navigate insurance prior authorizations for Zepbound, ensuring a smoother path to treatment.We also hear from two Ro patients, Colleen and Billy, who share their personal community stories and experiences with Ro's platform. They talk about how Ro's holistic approach—addressing everything from diabetes prevention to thyroid conditions like hypothyroidism and Hashimoto's disease—has empowered them to tackle their weight loss journeys and find sustainable health improvements.Ro's approach goes beyond just medication. With a focus on both physical and mental health, they create tailored treatment plans that consider each patient's unique challenges and provide long-term success. If you're looking for insights on safe weight loss solutions, GLP-1 medications, or navigating the complex world of weight management, this episode has you covered.Follow our guests! Billy Facebook: https://www.facebook.com/share/1687JSFHSa/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/in/billyscharmann?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_appiG: https://www.instagram.com/bill Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-425 Overview: In this episode we discuss updates on the treatment and management of obstructive sleep apnea (OSA). This is a common health concern, but it is often underdiagnosed and can have significant health impacts. We review its prevalence and standard treatments, highlighting the recently used medication therapy that has been found to be effective in treating OSA, particularly in individuals with obesity.  Episode resource links: https://www.aafp.org/pubs/afp/issues/2023/0300/uspstf-obstructive-sleep-apnea.html https://emedicine.medscape.com/article/295807-overview Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., ... & Bednarik, J. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., ... & US Preventive Services Task Force. (2022). Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. Jama, 328(19), 1945-1950. https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/ Guest: Mariyan L. Montaque, DNP, FNP-BC  Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

In this episode, host Dr. Seema Khosla explores a transformative development in sleep medicine: the FDA approval of tirzepatide for obstructive sleep apnea (OSA). Joined by an expert panel including Dr. Atul Malhotra, lead investigator of the SURMOUNT-OSA trial, and specialists Dr. Radhika Breaden, Dr. Jeremy McConnell, and Dr. Rafael Sepulveda-Acosta, the discussion examines how sleep clinicians can effectively incorporate this groundbreaking medication into their treatment protocols.  Discover key insights about the SURMOUNT-OSA trial results published in the New England Journal of Medicine, including the mechanisms behind AHI improvement beyond weight reduction alone. Learn practical implementation strategies for private practices, including documentation requirements for insurance approval, necessary baseline labs, and optimal patient follow-up protocols. The experts address crucial questions about Medicare coverage, long-term medication management, the need for retesting at goal weight, and considerations for transitioning patients already using GLP-1 medications like Ozempic or Wegovy.  This episode provides essential guidance for sleep medicine specialists considering expanding their treatment options beyond traditional PAP therapy, including collaborations with obesity medicine clinics and whether obtaining board certification in Obesity Medicine would benefit sleep clinicians. This timely discussion equips practitioners with the knowledge to navigate the intersection of sleep medicine and obesity treatment in managing OSA patients 

Send us a textWelcome back Rounds Table Listeners! In this throwback episode, Drs. Mike and John Fralick chat about five important research studies published in 2023:Hydrocortisone in Severe Community-Acquired Pneumonia (0:00 – 5:39).Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes (5:40 – 8:48).Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (8:49 – 12:29).Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection (12:30 – 17:49).Early versus Later Anticoagulation for Stroke with Atrial Fibrillation (17:50 – 23:38).And for the Good Stuff:The Beckham docuseries on Netflix (23:39 – 24:15)Upside Drinks (24:16 – 26:04).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

When to get follow-up labs after starting your diet RxXlear is exonerated!I've been taking tirzepatide and am within range of my desired weight. What is the protocol for coming off this medication?

Subscriber-only episodeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Sign The Petition for Avoidable Access to GLP-1s https://glp1collective.org/ ______________________________________________________________________We discuss Wegovy, Ozempic, Mounjaro, Zepbound, Rybelsus, Saxenda, and Victoza and the active ingredients Tirzepatide and Semaglutide. Unlike traditional media, our live sessions offer raw, real-time discussions on obesity treatments, where the community can engage directly in the comments, share their perspectives, and connect with experts and fellow patients. It's a space for honest dialogue, advocacy, and breaking the stigma around obesity, all while staying informed about the latest breakthroughs. Tonight, we are joined by @Downsidezed    / @thedownsized  ______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF_____________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy  Kim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Drs. Karl and Spencer discuss with Dr. Grant Tinsley all about the new analysis of how much "lean mass" is lost with tirzepatide, the most powerful medicine available for weight loss.Learn:The difference between fat free mass and lean mass and lean soft tissue and muscle.If GLP-1 medicines cause muscle loss specificallyHow to minimize muscle loss when taking these medicinesOur new study together.Click here for the tirzepatide paperClick here to see Dr. Grant Tinsely's InstagramClick here to join Vineyard